Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Pharmaceuticals & Biotech
Create a narrative
Aroa Biosurgery Community
ASX:ARX Community
1
Narratives
written by author
0
Comments
on narratives written by author
46
Fair Values set
on narratives written by author
Create a narrative
Aroa Biosurgery
Popular
Undervalued
Overvalued
Community Investing Ideas
Aroa Biosurgery
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
US Sales, TELA Bio And Enivo Will Fuel Success
Key Takeaways The dual-channel market strategy and strategic leadership hiring are set to enhance U.S. market penetration and significantly drive future revenue growth. New product approvals and strong validation through peer-reviewed studies are expected to bolster market credibility and diversify revenue streams.
View narrative
AU$0.83
FV
23.2% undervalued
intrinsic discount
18.13%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
32
users have followed this narrative
10 days ago
author updated this narrative
Your Valuation for
ARX
ARX
Aroa Biosurgery
Your Fair Value
AU$
Current Price
AU$0.64
71.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-19m
188m
2015
2018
2021
2024
2025
2027
2030
Revenue NZ$187.8m
Earnings NZ$38.2m
Advanced
Set Fair Value